Par

Mike Tirico, Curtis Strange, Suzy Whaley and Steve Melnyk join SiriusXM's Masters broadcast team

Retrieved on: 
Monday, March 21, 2022
Masters Tournament, LPGA, NFL, Augusta National Golf Club, Golf, Population, 2019 Men's Ice Hockey World Championships, NBA, List of halls and walks of fame, Business, Amateur, NHL, Music, PGA Tour, PGA, World Golf Hall of Fame, Tournament, Ryder Cup, 2011 LPGA Tour, Whaley, Augusta National Women's Amateur, World cup, PGA Tour on television, Sirius XM Canada, Safety, Sirius XM, Basketball, NBC, Attention, News, Sport, Par, Female, Masters Tournament Par-3 contest, Melnik, Lists of video games, Nightclub, Communications satellite, Entertainment

World Golf Hall of Fame member Curtis Strange and Steve Melnyk, who combined have competed in more than two dozen Masters Tournaments, will be the analysts.

Key Points: 
  • World Golf Hall of Fame member Curtis Strange and Steve Melnyk, who combined have competed in more than two dozen Masters Tournaments, will be the analysts.
  • Suzy Whaley, a trailblazer in her career as a player, golf executive and instructor, joins the SiriusXM team and will serve as an on-course reporter.
  • "We are thrilled to welcome Mike, Curtis, Steve and Suzy to our exceptional team of voices, and we're proud to deliver our listeners a top-notch broadcast befitting such a special event."
  • "I am thrilled to reconnect with Curtis, Steve and the great team that has been assembled for the SiriusXM broadcast.

Mike Tirico, Curtis Strange, Suzy Whaley and Steve Melnyk Join SiriusXM's Masters Broadcast Team

Retrieved on: 
Monday, March 21, 2022
Company, Masters Tournament, LPGA, NFL, Augusta National Golf Club, Golf, Population, NASDAQ, 2019 Men's Ice Hockey World Championships, NEW, NBA, List of halls and walks of fame, SIRI, Amateur, NHL, PGA Tour, PGA, World Golf Hall of Fame, Radio, Tournament, Ryder Cup, 2011 LPGA Tour, Whaley, Augusta National Women's Amateur, World cup, PGA Tour on television, Sirius XM, Basketball, NBC, Attention, News, Sport, Par, Female, Masters Tournament Par-3 contest, Melnik, Lists of video games, Nightclub, Communications satellite, Entertainment, Music

NEW YORK, March 21, 2022 /PRNewswire/ -- SiriusXM announced today that it has added several acclaimed voices to its broadcast team for the 2022 Masters Tournament, April 7-10.  

Key Points: 
  • World Golf Hall of Fame member Curtis Strange and Steve Melnyk, who combined have competed in more than two dozen Masters Tournaments, will be the analysts.
  • Suzy Whaley, a trailblazer in her career as a player, golf executive and instructor, joins the SiriusXM team and will serve as an on-course reporter.
  • "We are thrilled to welcome Mike, Curtis, Steve and Suzy to our exceptional team of voices, and we're proud to deliver our listeners a top-notch broadcast befitting such a special event."
  • "I am thrilled to reconnect with Curtis, Steve and the great team that has been assembled for the SiriusXM broadcast.

Individuals flock to forestry investment through Par Equity specialist fund

Retrieved on: 
Wednesday, March 2, 2022
People, Par, IRR, Investment, Climate change, IHT, Income, Forestry, Growth, CGT, Sale, Forest, Financial services, Security (finance)

Having been committed to the sector for more than 10 years, Par Equity, the specialist forestry investor, has reported unprecedented high net worth demand for itsthird and newly-launched Forestry Fund 'Par Forestry III LP'.

Key Points: 
  • Having been committed to the sector for more than 10 years, Par Equity, the specialist forestry investor, has reported unprecedented high net worth demand for itsthird and newly-launched Forestry Fund 'Par Forestry III LP'.
  • The fund plans to raise up to 10m per year to fund investments in existing forests and new planting.
  • Par Forestry III LP requires a minimum investment of 50,000 and is targeting an IRR consistent with the returns produced for the UK forestry sector.
  • Paul Atkinson, Partner in charge of forestry investments at Par Equity said: "It is not surprising there is growing interest in investing in the forestry sector, since it delivers environmentally friendly returns in a sustainable way.

ClubCorp Continues to Expand Presence in Third-Party Management Space

Retrieved on: 
Wednesday, February 16, 2022
Par, Midlothian Country Club, District, PGA National Resort and Spa, CLM, Club, Golf, Tennis, GLOBE, Technology, Duke Diet and Fitness Center, Drink, Partnership, Garden, National Directorate for Personal Data Protection, ClubCorp, Staple, Growth, Catalina Foothills, Arizona, Country club, Industry, Match, Retail, Hotel, Amusement park, Management

The opportunity to strategically tap into the vast tools and resources available through the connectivity to ClubCorp, is something that were incredibly excited about.

Key Points: 
  • The opportunity to strategically tap into the vast tools and resources available through the connectivity to ClubCorp, is something that were incredibly excited about.
  • We saw a tremendous opportunity to expand our presence in third-party management in 2018 with the formation of ClubLife Management, said David Pillsbury, ClubCorps Chief Executive Officer.
  • ClubLife Management, an affiliate of ClubCorp, provides full-service management to private clubs, premier resort properties and city clubs.
  • Since its founding in 1957, Dallas-based ClubCorp has operated with the central purpose of Building Relationships and Enriching Lives.

Convey Health Solutions Holdings, Inc. Appoints Paul V. Campanelli to Board of Directors

Retrieved on: 
Tuesday, February 15, 2022
Par, NYSE, Medco Health Solutions, Medicare, Audit committee, Business, Time, CEO, Medicare Advantage, Pharmacy, Solution, Bobby Convey, Business development, Private Securities Litigation Reform Act, Endo International, Leadership, Board of directors, Technology, Compliance, US General Accounting Office Building, Board, TPG, Acquisition, Laboratory, Growth, Industry, Pharmaceutical industry, Risk management, Management

FORT LAUDERDALE, Fla., Feb. 15, 2022 /PRNewswire/ --Convey Health Solutions Holdings, Inc. (NYSE: CNVY) ("Convey"), a leading healthcare technology and services company, today announced the appointment of Paul Campanelli to its Board of Directors ("Board").

Key Points: 
  • FORT LAUDERDALE, Fla., Feb. 15, 2022 /PRNewswire/ --Convey Health Solutions Holdings, Inc. (NYSE: CNVY) ("Convey"), a leading healthcare technology and services company, today announced the appointment of Paul Campanelli to its Board of Directors ("Board").
  • Convey Health Solutions is a specialized healthcare technology and services company that is committed to providing clients with healthcare-specific, compliant member support solutions utilizing technology, engagement, and analytics.
  • Convey Health Solutions' administrative solutions for government-sponsored health plans help to optimize member interactions, ensure compliance, and support end-to-end Medicare processes.
  • Convey Health Solutions' clients include some of the nation's leading health insurance plans and pharmacy benefit management firms.

Dr. Reddy's Laboratories Announces the Launch of Its Authorized Generic Version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market

Retrieved on: 
Wednesday, February 9, 2022
FDA, Health, Other Science, Research, Pharmaceutical, Science, Pandemic, Industry, NSE, U.S. Securities and Exchange Commission, Mission statement, Epidemic, Lists of disasters, Vial, API, Annual report, RDY, USP, Pain management, Dermatology, Patient, Par, Security (finance), NYSE, Coronavirus, CIS, Regulation of tobacco by the U.S. Food and Drug Administration, USFDA, Food, BSE, Health, Disease, Risk factor (finance), Mortality, Risk, COVID-19, Pharmaceutical industry

We are pleased to provide this important authorized generic product to patients, especially in these difficult times of COVID-19, says Marc Kikuchi, Chief Executive Officer, North America Generics, Dr. Reddys Laboratories Inc.

Key Points: 
  • We are pleased to provide this important authorized generic product to patients, especially in these difficult times of COVID-19, says Marc Kikuchi, Chief Executive Officer, North America Generics, Dr. Reddys Laboratories Inc.
  • The VASOSTRICT brand market had U.S. sales of approximately $878.5 million MAT for the most recent twelve months ending in December 2021 according to IQVIA Health*.
  • Dr. Reddys Vasopressin Injection, USP, is supplied in a carton of 25 single-dose vials each containing vasopressin 1 mL at 20 units/mL.
  • Dr. Reddys offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.

Endo Announces Launch of Ready-to-Use VASOSTRICT® (vasopressin injection, USP) in Pre-Mix Bottles

Retrieved on: 
Monday, February 7, 2022
NASDAQ, Private Securities Litigation Reform Act, Industry, RTU, Phrase, Senior, General manager, Multimedia, Public expenditure, Annual report, Endo International, USP, Risk, Hospital, U.S. Securities and Exchange Commission, Par, Safety, Compliance, Life, Workflow, Health, Legislation, LinkedIn, View, Bankruptcy, Pharmaceutical industry

Ready-to-use, or RTU, products help streamline operations for hospitals by eliminating the need to prepare or transfer the product before patient administration.

Key Points: 
  • Ready-to-use, or RTU, products help streamline operations for hospitals by eliminating the need to prepare or transfer the product before patient administration.
  • Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies.
  • Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward.
  • Endo expressly disclaims any intent or obligation to update these forward-looking statements, except as required to do so by law.

Endo Announces Launch of Ready-to-Use VASOSTRICT® (vasopressin injection, USP) in Pre-Mix Bottles

Retrieved on: 
Monday, February 7, 2022
NASDAQ, Private Securities Litigation Reform Act, Industry, RTU, Phrase, Senior, General manager, Public expenditure, Annual report, Endo International, USP, Risk, Hospital, U.S. Securities and Exchange Commission, Par, Safety, Compliance, Life, Workflow, Health, Legislation, LinkedIn, Bankruptcy, Pharmaceutical industry

Ready-to-use, or RTU, products help streamline operations for hospitals by eliminating the need to prepare or transfer the product before patient administration.

Key Points: 
  • Ready-to-use, or RTU, products help streamline operations for hospitals by eliminating the need to prepare or transfer the product before patient administration.
  • Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies.
  • Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward.
  • Endo expressly disclaims any intent or obligation to update these forward-looking statements, except as required to do so by law.

Par Pacific Announces Fourth Quarter 2021 Earnings Release and Conference Call Schedule

Retrieved on: 
Tuesday, February 1, 2022
Par Pacific Holdings, Natural gas, Investor, Pacific Northwest, LLC, Par, GLOBE, Central Time, New, NYSE, Internet service provider, Rocky Mountains

HOUSTON, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (Par Pacific) today announced that it will release its fourth quarter 2021 results after the New York Stock Exchange closes on Wednesday, February 23, 2022.

Key Points: 
  • HOUSTON, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (Par Pacific) today announced that it will release its fourth quarter 2021 results after the New York Stock Exchange closes on Wednesday, February 23, 2022.
  • The full text of the release will be available on Par Pacifics website at http://www.parpacific.com .
  • In the Pacific Northwest and the Rockies, Par Pacific owns and operates 60,000 bpd of combined refining capacity, related multimodal logistics systems and 30 retail locations.
  • Par Pacific also owns 46% of Laramie Energy, LLC, a natural gas production company with operations and assets concentrated in Western Colorado.

Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin

Retrieved on: 
Tuesday, January 18, 2022
FDA, Health, Other Health, General Health, Pharmaceutical, Cardiology, Vasodilatory shock, Forward-looking statement, Sepsis, Patient, Research, Hypotension, Biotechnology, Private Securities Litigation Reform Act, European Medicines Agency, SEC, Douglas v. U.S. District Court ex rel Talk America, CNS, Regulation of tobacco by the U.S. Food and Drug Administration, Catecholamine, Endo International, COVID-19, LTM, Growth, Par, Medication, Fulvestrant, U.S. Securities and Exchange Commission, Nasdaq, Blood pressure, Marketing, Phrase, Company, Drug development, ANDA, District, Contract, Food, FDA, Compliance, Security (finance), District court, Failure, Critical care, Pharmaceutical industry, Eagle

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (Eagle or the Company) today announced the commercial availability of its recently approved product, vasopressin, an A-rated generic alternative to Vasostrict, with 180 days of marketing exclusivity.

Key Points: 
  • Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (Eagle or the Company) today announced the commercial availability of its recently approved product, vasopressin, an A-rated generic alternative to Vasostrict, with 180 days of marketing exclusivity.
  • The Eagle team has worked very hard to advance vasopressin for patients in need.
  • On August 31, 2021, the U.S. District Court for the District of Delaware held that Eagles proposed vasopressin product does not infringe any of the patents Par asserted against Eagle.
  • Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise.